Table 3 Relative percent of ‘no benefit’, ‘harm’, and ‘benefit’ assuming a three and four year waiting time and 20% of wait list inactive with 2.2-fold higher mortality rate
From: Eligibility for the kidney transplant wait list: a model for conceptualizing patient risk
Mortality: deaths per 100 patient years (Life expectancy) Waiting time | No benefit (%)a | Harm (%) | Benefit (%) | Ratio harm/benefit |
|---|---|---|---|---|
15 (6.7 years) | ||||
3 year | 36 | 25 | 39 | 0.63 |
4 year | 45 | 20 | 33 | |
20 (5 years) | ||||
3 year | 45 | 27 | 29 | 0.93 |
4 year | 55 | 22 | 23 | |
25 (4 years) | ||||
3 year | 53 | 27 | 20 | 1.3 |
4 year | 63 | 22 | 15 | |
30 (3.3 years) | ||||
3 year | 60 | 26 | 14 | 1.8 |
4 year | 70 | 19 | 11 | |
35 (2.9 years) | ||||
3 year | 65 | 25 | 11 | 2.4 |
4 year | 75 | 18 | 8 |